Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Orientation Marketing, a pharmaceutical and life science marketing agency, opened a new office in Espoo, Finland to serve its growing client base in the Nordic and EU regions.
read more
ORIG3N, announced the launch of a unique partnership with Innovasalud to bring health and wellness DNA Tests to Latin America.
read more
Origenis has entered into a global license and collaboration agreement with Expansion Therapeutics to research and discover small molecule compounds targeting RNA-mediated diseases.
read more
Monday, November 03, 2025
Abzena announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug ...
read more
Wednesday, December 14, 2016
The Wisconsin Technology Innovation Initiative (Wi2), a non-profit organization formed to support the School of Medicine and Public Health at the University of Wisconsin-Madison, and Orion Corporation, a Finnish pharmaceutical and diagnostics ...
read more
Orion Contract Manufacturing has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital.
read more
Ortho Clinical Diagnostics announced an international distribution and co-promotion agreement with Thermo Fisher Scientific to provide 14 assays used to monitor therapeutic drugs, immunosuppressive drugs and drugs of abuse.
read more
OSE Immunotherapeutics and Cenexi, a French contract development and manufacturing organization (CDMO), announced the signature of an agreement whereby Cenexi will manufacture clinical batches of CoVepiT, OSE Immunotherapeutics' vaccine candidate ...
read more
Thursday, November 07, 2019
OSE Immunotherapeutics announced a new licensing deal with Chong Kun Dang (CKD) Pharmaceutical Corporation for Tedopi.
read more
Wednesday, March 18, 2020
OSE Immunotherapeutics and Servier announced the execution of an amendment to the two-step global licensing option agreement for exclusive global rights to interleukin-7 receptor antagonist OSE-127.
read more
Tuesday, October 06, 2015
Osmotica Pharmaceutical has announced the appointment of Samer Kaba, M.D. as Vice President, Head of Global Clinical Development and Medical Affairs.
read more
Wednesday, April 02, 2014
OsoBio has appointed Catherine R. Buck director of manufacturing. In her capacity, Buck is responsible for ensuring that OsoBio’s operations comply with current Good Manufacturing Practices (cGMP) as they apply to the manufacturing of injectable ...
read more
OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s
continued compliance with Current Good Manufacturing Practices (cGMP), including quality
systems, ...
read more
OsoBio has named Lindsey Pruitt manager of new business development for its East Coast market.
read more
As part of OsoBio’s quality control department, the microbiology and chemistry laboratories that Larese now directs are responsible for environmental monitoring, analytical method development, and testing all incoming raw materials, components, and ...
read more